LLY

1,008.17

+0.84%↑

JNJ

231.28

+1.24%↑

ABBV

212

+2.62%↑

UNH

399.28

+0.45%↑

AZN

185.47

-0.15%↓

LLY

1,008.17

+0.84%↑

JNJ

231.28

+1.24%↑

ABBV

212

+2.62%↑

UNH

399.28

+0.45%↑

AZN

185.47

-0.15%↓

LLY

1,008.17

+0.84%↑

JNJ

231.28

+1.24%↑

ABBV

212

+2.62%↑

UNH

399.28

+0.45%↑

AZN

185.47

-0.15%↓

LLY

1,008.17

+0.84%↑

JNJ

231.28

+1.24%↑

ABBV

212

+2.62%↑

UNH

399.28

+0.45%↑

AZN

185.47

-0.15%↓

LLY

1,008.17

+0.84%↑

JNJ

231.28

+1.24%↑

ABBV

212

+2.62%↑

UNH

399.28

+0.45%↑

AZN

185.47

-0.15%↓

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorGezondheidszorg

9.15 5.9

Strong Buy

Prijsupdate 14 mei 2026, 14:42 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.52

Max

10

Belangrijke statistieken

By Trading Economics

Inkomsten

-69M

-102M

Verkoop

-10M

34M

EPS

-5.69

Winstmarge

-299.886

Werknemers

228

EBITDA

4.7M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+97.31% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

42M

199M

Vorige openingsprijs

3.25

Vorige sluitingsprijs

9.15

Nieuwssentiment

By Acuity

50%

50%

162 / 346 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mei 2026, 22:54 UTC

Winsten

Xero Lifts Annual Earnings 18%, Flags More Growth Ahead

DJ

Lezen

13 mei 2026, 23:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

13 mei 2026, 23:51 UTC

Marktinformatie

Australian Consumer Spending Is Holding Up; RBA Watching -- Market Talk

DJ

Lezen

13 mei 2026, 23:45 UTC

Marktinformatie

Nikkei May Rise After Overnight U.S. Tech Gains -- Market Talk

DJ

Lezen

13 mei 2026, 23:45 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

13 mei 2026, 23:17 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Net Profit Beat FactSet-Compiled Consensus

DJ

Lezen

13 mei 2026, 23:16 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Net KRW635.22B Vs. Net KRW609.03B >000810.SE

DJ

Lezen

13 mei 2026, 23:15 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Oper Pft KRW861.13B Vs. Pft KRW792.36B >000810.SE

DJ

Lezen

13 mei 2026, 23:14 UTC

Winsten

Samsung Fire & Marine Insurance 1Q Rev KRW6.676T Vs. KRW6.106T >000810.SE

DJ

Lezen

13 mei 2026, 23:02 UTC

Marktinformatie
Winsten

Cisco Product Demand Climbing Even Without Hyperscalers -- Market Talk

DJ

Lezen

13 mei 2026, 22:59 UTC

Marktinformatie
Winsten

Cisco Boosted by Tech Infrastructure Upgrade Cycle -- Market Talk

DJ

Lezen

13 mei 2026, 22:24 UTC

Winsten

Xero FY U.S. Organic Revenue Growth 30%>XRO.AU

DJ

Lezen

13 mei 2026, 22:23 UTC

Winsten

Xero FY International Organic Revenue Growth 25%>XRO.AU

DJ

Lezen

13 mei 2026, 22:23 UTC

Winsten

Xero FY International Revenue Growth 47%>XRO.AU

DJ

Lezen

13 mei 2026, 22:22 UTC

Winsten

Xero FY Australia, New Zealand Revenue Up 18% on Year >XRO.AU

DJ

Lezen

13 mei 2026, 22:19 UTC

Winsten

Xero FY Australia, New Zealand Revenue Up 17% in Constant Currency>XRO.AU

DJ

Lezen

13 mei 2026, 22:19 UTC

Winsten

Xero FY Net Customer Additions 506,000 Vs. 254,000>XRO.AU

DJ

Lezen

13 mei 2026, 22:18 UTC

Winsten

Xero FY Rule of 40: 48.5% Vs. 44.3%>XRO.AU

DJ

Lezen

13 mei 2026, 22:16 UTC

Winsten

Xero: Ebitda Guidance Includes NZD55M of Incremental U.S. Brand Spend>XRO.AU

DJ

Lezen

13 mei 2026, 22:15 UTC

Winsten

Xero Expects FY27 Adjusted Ebitda of NZD860M-NZD920M>XRO.AU

DJ

Lezen

13 mei 2026, 22:15 UTC

Winsten

Xero Expects FY27 Operating Revenue of NZD3.62B-NZD3.73B>XRO.AU

DJ

Lezen

13 mei 2026, 22:13 UTC

Winsten

Xero FY Operating Expenses 70.5% of Operating Revenue Vs. 71.8%>XRO.AU

DJ

Lezen

13 mei 2026, 22:12 UTC

Winsten

Xero FY Free Cash Flow NZD554.0M Vs. NZD506.7M>XRO.AU

DJ

Lezen

13 mei 2026, 22:11 UTC

Winsten

Xero FY Adjusted Ebitda NZD757.4M Vs. NZD641.8M>XRO.AU

DJ

Lezen

13 mei 2026, 22:11 UTC

Winsten

Xero FY Ebitda NZD789.5M Vs. NZD638.5M>XRO.AU

DJ

Lezen

13 mei 2026, 22:10 UTC

Winsten

Xero Did Not Declare a Dividend>XRO.AU

DJ

Lezen

13 mei 2026, 22:10 UTC

Winsten

Xero FY Rev NZD2.75B Vs. NZD2.10B >XRO.AU

DJ

Lezen

13 mei 2026, 22:09 UTC

Winsten

Xero FY Net NZD167.4M Vs. Net NZD227.8M >XRO.AU

DJ

Lezen

13 mei 2026, 22:00 UTC

Winsten

Cisco to Shed Jobs for All-In AI Push -- Update

DJ

Lezen

13 mei 2026, 21:11 UTC

Winsten

Cisco Earnings and Revenue Beat Estimates on Strong AI Demand. Its Shares Surge. -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

97.31% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 17.6 USD  97.31%

Hoogste 28 USD

Laagste 13 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

162 / 346 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,008.17

↑ +0.84%

JNJ

Johnson and Johnson

231.28

↑ +1.24%

ABBV

AbbVie Inc

212

↑ +2.62%

UNH

UnitedHealth Group Inc

399.28

↑ +0.45%

AZN

AstraZeneca PLC

185.47

↓-0.15%
help-icon Live chat